⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for cscc

Every month we try and update this database with for cscc cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell CarcinomaNCT03889912
Cutaneous Squam...
Basal Cell Carc...
Cemiplimab
18 Years - Regeneron Pharmaceuticals
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced CancersNCT03212404
Lung Neoplasms
Carcinoma, Non-...
Carcinoma, Smal...
Malignant Mesot...
Head and Neck C...
Melanoma
Merkel Cell Car...
Renal Cell Carc...
Urothelial Carc...
Classical Hodgk...
Cutaneous Squam...
Non Hodgkin Lym...
Endometrial Can...
CK-301 (cosibel...
18 Years - Checkpoint Therapeutics, Inc.
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced CancersNCT03212404
Lung Neoplasms
Carcinoma, Non-...
Carcinoma, Smal...
Malignant Mesot...
Head and Neck C...
Melanoma
Merkel Cell Car...
Renal Cell Carc...
Urothelial Carc...
Classical Hodgk...
Cutaneous Squam...
Non Hodgkin Lym...
Endometrial Can...
CK-301 (cosibel...
18 Years - Checkpoint Therapeutics, Inc.
A Beta-only IL-2 ImmunoTherapY StudyNCT05086692
Advanced Solid ...
Unresectable So...
Clear Cell Rena...
Triple Negative...
Non-Small Cell ...
Non-Small Cell ...
Colorectal Canc...
Gastric Cancer
Cervical Cancer
Basal Cell Carc...
Bladder Cancer
Merkel Cell Car...
Squamous Cell C...
Cutaneous Squam...
Pleural Mesothe...
Esophageal Canc...
Endometrial Car...
Solid Tumor
Solid Tumor, Ad...
MSI-H Solid Mal...
Cancer With A H...
Epithelial Ovar...
Primary Periton...
Gastroesophagea...
Acral Melanoma
Mucosal Melanom...
Cutaneous Melan...
DMMR Solid Mali...
Fallopian Tube ...
Ovarian Cancer
MSI-H Cancer
DMMR Cancer
Pancreas Adenoc...
Skin Cancer
MDNA11
Pembrolizumab
18 Years - Medicenna Therapeutics, Inc.
Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the SkinNCT01059305
Skin Cancer
Erlotinib
18 Years - M.D. Anderson Cancer Center
Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.NCT04812535
SCC - Squamous ...
IFX-1
IFX-1 + pembrol...
18 Years - InflaRx GmbH
Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.NCT04812535
SCC - Squamous ...
IFX-1
IFX-1 + pembrol...
18 Years - InflaRx GmbH
A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic CancerNCT04916002
Merkel Cell Car...
Cutaneous Squam...
Basal Cell Carc...
Triple Negative...
Non-Small Cell ...
Oropharynx Squa...
vidutolimod
cemiplimab
18 Years - Regeneron Pharmaceuticals
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced CancersNCT03212404
Lung Neoplasms
Carcinoma, Non-...
Carcinoma, Smal...
Malignant Mesot...
Head and Neck C...
Melanoma
Merkel Cell Car...
Renal Cell Carc...
Urothelial Carc...
Classical Hodgk...
Cutaneous Squam...
Non Hodgkin Lym...
Endometrial Can...
CK-301 (cosibel...
18 Years - Checkpoint Therapeutics, Inc.
A Study of SGN-B6A in Advanced Solid TumorsNCT04389632
Carcinoma, Non-...
Squamous Cell C...
HER2 Negative B...
Esophageal Squa...
Esophageal Aden...
Gastroesophagea...
Ovarian Neoplas...
Cutaneous Squam...
Exocrine Pancre...
Urinary Bladder...
Uterine Cervica...
Stomach Neoplas...
sigvotatug vedo...
pembrolizumab
cisplatin
carboplatin
18 Years - Seagen Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: